According to Immix Biopharma's latest financial reports the company's current earnings are N/A. In 2023 the company made an earning of -โฌ15.31 Million a decrease over its 2022 earnings that were of -โฌ7.91 Million. The earnings displayed on this page is the company's Pretax Income.